Susan Laura Smith - Net Worth and Insider Trading
Susan Laura Smith Net Worth
The estimated net worth of Susan Laura Smith is at least $474,852 dollars as of 2024-09-20. Susan Laura Smith is the SVP & CHIEF COMMERCIAL OFFICER of Y-mAbs Therapeutics Inc and owns about 33,918 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $474,852. Details can be seen in Susan Laura Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan Laura Smith has not made any transactions after 2024-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan Laura Smith
Susan Laura Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Laura Smith owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Susan Laura Smith’s form 4 insider trades.
Insider Ownership Summary of Susan Laura Smith
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-03-05 | Senior Vice President & CCO |
Susan Laura Smith Latest Holdings Summary
Susan Laura Smith currently owns a total of 1 stock. Susan Laura Smith owns 33,918 shares of Y-mAbs Therapeutics Inc (YMAB) as of March 5, 2024, with a value of $474,852.
Latest Holdings of Susan Laura Smith
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-03-05 | 33,918 | 14.00 | 474,852 |
Holding Weightings of Susan Laura Smith
Susan Laura Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Laura Smith has made a total of 1 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 1,682 shares on March 5, 2024, which brought Susan Laura Smith around $27,837.
Insider Trading History of Susan Laura Smith
- 1
Susan Laura Smith Trading Performance
Susan Laura Smith Ownership Network
Susan Laura Smith Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Susan Laura Smith is the Senior Vice President & CCO of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and Sr. VP and COO Joris Wilms .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Susan Laura Smith made 1 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 1,682. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 380,768 shares made by Biotech Aps Wg , and a net purchase of 380,768 shares made by Johan Wedell-wedellsborg .
In summary, during the past 3 months, insiders sold 150,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 141,170 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Susan Laura Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Laura Smith. You might contact Susan Laura Smith via mailing address: 5 Overlook Ct, Lambertville Nj 08530.